Legal Representation
Attorney
Kisuk Lee
USPTO Deadlines
Next Deadline
1709 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240827)
Due Date
August 27, 2030
Grace Period Ends
February 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 5, 2025 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Mar 1, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Feb 13, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Feb 13, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 27, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 27, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 27, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 17, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 31, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 31, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 7, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 28, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 28, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 28, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 26, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 26, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 26, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 26, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 25, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Oct 2, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 2, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 20, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 19, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 7, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 2, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Veterinary preparations for oncology, cancers; vaccines; non-prescription medicines for oncology, cancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologics, capsule, tablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposes, namely, for the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; antibodies for medical purposes; Pharmaceutical preparations for oncology and precision medicine, cancer; radioisotope markers for therapeutic or diagnostic use
Class 042
Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicine, cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes
Classification
International Classes
005
042